logo

For the Inventor, By the Inventor

Red Bank, NJ, United States of America

Otto D Hensens

USPTO Granted Patents = 43

 

Average Co-Inventor Count = 6.1

ph-index = 9

Forward Citations = 342(Granted Patents)


Location History:

  • Middletown, NJ (US) (1984)
  • Red Bank, NJ (US) (1985 - 1999)

Company Filing History:

goldMedal43 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1984-1999

Loading Chart...
Loading Chart...
Areas of Expertise:
Antifungal Agents
Antiparasitic Agents
Antibiotic Compounds
Squalene Synthetase Inhibitors
HMG-CoA Reductase Inhibitors
Indole Diterpene Alkaloids
Immunosuppressant Macrolides
Renin-Inhibitory Compounds
Biologically Active Compounds
Therapeutic Virginiamycin Analogues
Fermentation Products
Anti-Inflammatory Compounds
43 patents (USPTO):Explore Patents
1. 5994412 - Bis-aryl ethers, compositions containing such compounds and methods of (1999-11-30),
2. 5770587 - Antifungal agents (1998-06-23),
3. 5614546 - Antiparasitic agents (1997-03-25),
4. 5541208 - Indole diterpene alkaloid compounds (1996-07-30),
5. 5411985 - Gamma-pyrone-3-acetic acid as an inhibitor or interleukin-1 .beta. (1995-05-02),
6. 5399587 - Biologically active compounds (1995-03-21),
7. 5399582 - Antiparasitic agents (1995-03-21),
8. 5366880 - Antibiotic agent (1994-11-22),
9. 5306708 - Antibiotic agent (1994-04-26),
10. 5276055 - Antibiotic agents (1994-01-04),
11. 5276054 - Substituted hexahydrobenzopyran derivatives as angiotensin II antagonists (1994-01-04),
12. 5202309 - Antibiotic cyclopeptide fermentation product (1993-04-13),
13. 5189050 - Fermentation analogs of Virginiamycin M.sub.1 to treat panic and anxiety (1993-02-23),
14. 5183826 - Antiviral agent (1993-02-02),
15. 5164375 - Antifungal agent (1992-11-17),

Title: The Innovative Contributions of Otto D. Hensens in Medicinal Chemistry

Introduction: Otto D. Hensens, based in Red Bank, NJ, is a prolific inventor known for his significant contributions to medicinal chemistry. With a remarkable portfolio of 43 patents, Hensens has made a lasting impact on the field, particularly in the development of pharmaceutical compounds.

Latest Patents: Among his most recent patents, Hensens has developed compounds that inhibit the oncoprotein Raf. One notable patent involves bis-aryl ethers, which includes pharmaceutical compositions and methods for treating cancer. The patent details a compound represented by a specific formula, highlighting its potential applications in cancer treatment. Additionally, Hensens has disclosed novel antifungal agents, which exhibit significant antifungal activity, thus broadening the scope of therapeutic options available in medicinal chemistry.

Career Highlights: Hensens has dedicated his career to innovation at Merck & Company, Inc., a leading pharmaceutical company. His work focuses on the search for new therapeutic agents, contributing to both the academic and practical realms of drug discovery and development.

Collaborations: Throughout his esteemed career, Hensens has collaborated with esteemed colleagues, including Jerrold M. Liesch and Deborah L. Zink. These partnerships have bolstered his ability to innovate and expand the therapeutic potential of his inventions.

Conclusion: Otto D. Hensens exemplifies the spirit of innovation within the pharmaceutical industry. His extensive patent portfolio underscores his commitment to enhancing public health through the development of novel therapeutic compounds. As he continues his work, Hensens remains a prominent figure in medicinal chemistry, influencing the future of drug discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…